MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR FOR THE TREATMENT OF THE AMYOTROPHIC LATERAL SCLEROSIS, MOTONEURON DISEASE, CHARCOT DISEASE (KNOWN AS LOU GEHRIG DISEASE IN THE USA); AND FOR THE TREATMENT OF CANCERS